Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030
March 12, 2020

Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/ As one of PSMF’s longest-standing board members, serving since 2013, Dr. Ramsay has been an advocate for patient......

Saudi surgical conference concludes in Riyadh
March 12, 2020

RIYADH: The 13th edition of the Saudi General Surgery Society Conference — organized by the Saudi General Surgery Society (SSGS) — concluded in Riyadh, the Saudi Press Agency reported on Wednesday.

The three-day conference was attended by doctors and consultants from a number of different countries and examined the latest surgical research and scientific papers, as well as providing"...

Heart failure remains a major cause of death and disability
March 12, 2020

RIYADH — Despite significant advances, heart failure remains a major cause of death and disability worldwide. Unfortunately, the problem is growing and accordingly the cost of chronic care and hospitalization are escalating.

Novel approaches are needed to reduce the burden of heart failure as well as to improve the quality of life of these patients.

Today more than ever, heart failure has to become a political and health care system"...

Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance
March 12, 2020

Regulatory News:

Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded its raised guidance for full-year 2019 on both net sales and EBITDA.

FINANCIAL PERFORMANCE: STRONG"...

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial
March 11, 2020

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients. The addition of ixazomib to lenalidomide and dexamethasone resulted in an improvement in median progression-free survival (PFS) of 13.5 months (35.3 months versus 21.8 months; hazard ratio [HR] 0.83; p=0.073); however, it did not meet the threshold for statistical significance. The safety profile associated with NINLARO from the TOURMALINE-MM2 trial was generally consistent with the existing prescribing information. Results from the TOURMALINE-MM2 study will be submitted to an upcoming medical congress.......

Sinterex named Best 3D-Printed Healthcare Products Manufacturer Middle East
March 11, 2020

Global Health & Pharma (GHP), a global information sharing platform & a multi-disciplinary members community announced winners of the 2019 Technology Awards this month and recognised Sinterex as Best 3D-Printed Healthcare Products Manufacturer – Middle East.

In its announcement, GHP said, “Technology is a great force for change across numerous industries, sectors and"...

Saudi health ministry announces five new coronavirus cases
March 10, 2020

RIYADH: Saudi Arabia’s Ministry of Health announced on Monday evening five new cases infected with coronavirus, increasing the total number in the Kingdom to 20.

Three of the five cases – a man and two women from Saudi Arabia – were already in quarantine after returning from Iran and Iraq. They were transferred to a hospital in the Eastern Province.

The"...

Saudi Arabia provides $10m in global fight against coronavirus
March 10, 2020

Saudi Arabia has provided $10 million to the World Health Organisation (WHO) for the implementation of urgent measures to minimise the spread of the new coronavirus, known as Covid-19.

This support came in response to an urgent appeal by WHO to all countries aimed at intensifying efforts to take global measures to combat the spread of the disease, Saudi News Agency reported.

The"...

Saudi cordons off Qatif region in bid to contain coronavirus spread
March 9, 2020

Saudi authorities have cordoned off the eastern Qatif region, a stronghold of the kingdom's Shiite minority, in a bid to contain the fast-spreading coronavirus, the interior ministry said Sunday.

'Given that all 11 recorded positive cases of the new coronavirus are from Qatif... it has been decided... to temporarily suspend entry and exit from Qatif,' the ministry said in a"...

Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19
March 9, 2020

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with COVID-19, while also studying whether Takeda’s currently marketed and pipeline products may be effective treatments for infected patients. SARS-CoV-2 is the virus that causes COVID-19. Hyperimmune globulins are plasma derived-therapies that have previously been shown to be effective in the treatment of severe acute viral respiratory infections and may be a treatment option for COVID-19. As a leader in plasma-derived therapies with more than 75 years of experience in the development of plasma-derived products, Takeda has the......